Prof. Bernhard Baune highlights the importance of functional recovery for patients with depression and the role of vortioxetine (Brintellix®, Lundbeck) in achieving global functional recovery.

Prof. Michael R. McClung discusses the various therapeutic options for osteoporosis, with emphasis on denosumab, a first-line anti-osteoporotic drug with a novel mechanism of action.

Eminent speakers discuss Singapore's ageing population at the PACE Symposium: Overview of elderly care needs in Singapore; Managing the elderly with multi-morbidity; Optimising outcomes in PPI therapy; ACOS (Asthma-COPD Overlap Syndrome) with elderly patients: Inhaler therapy among the frail elderly

LAI antipsychotics can help improve adherence to schizophrenia therapy to minimize relapse episodes. Prof. Nagesh Pai discusses the benefits and clinical considerations of LAI antipsychotics, with a focus on aripiprazole once-monthly (Abilify Maintena®).

Rasagiline (Azilect®, Lundbeck) is an irreversible monoamine oxidase-B (MAO-B) inhibitor for the treatment of Parkinson's. It has been available in Europe and the United States for around a decade. With the approval of rasagiline in Singapore, Prof. Fabrizio Stocchi presents the pivotal clinical trials of the drug and its role in the overall management of Parkinson's.

Human milk oligosaccharides (HMOs) in breast milk promote paediatric gut health and immunity. Learn about HMOs and how infant formulas with 2'-fucosyllactose HMO may help close the health gap between breast-fed and formula-fed babies.

Nutrition experts Dr Lisa Renzi-Hammond and Dr Ardythe Morrow discuss the role of lutein and 2'-fucosyllactose in optimizing cognitive performance, gut health, and immune function in babies

Atrial fibrillation is the most prevalent arrhythmia in elderly people worldwide, and NOAC therapy has been shown to reduce the risk of stroke and all-cause mortality in patients with AF. Prof. Fox shares his expert insights on how to select the right NOAC for the right patient.